|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.350 EGP | +1.50% |
|
+8.00% | +18.42% |
| May. 17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| Feb. 19 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 770M 15.07M 13.31M 12.18M 11.32M 21.13M 1.45B 21.63M 147M 57.69M 718M 56.6M 55.36M 2.45B | P/E 2026 * |
22.5x | P/E 2027 * | 15x |
|---|---|---|---|---|---|
| Enterprise Value | 690M 13.51M 11.93M 10.92M 10.15M 18.94M 1.3B 19.39M 132M 51.72M 644M 50.74M 49.63M 2.2B | EV / Sales 2026 * |
0.58x | EV / Sales 2027 * | 0.43x |
| Free-Float |
42% | Yield 2026 * |
2.22% | Yield 2027 * | 2.96% |
| 1 day | +1.50% | ||
| 1 week | +8.00% | ||
| Current month | +12.50% | ||
| 1 month | +8.87% | ||
| 3 months | +17.39% | ||
| 6 months | +23.85% | ||
| Current year | +18.42% |
| 1 week | 1.3 |  | 1.4 |
| 1 month | 1.17 | | 1.4 |
| Current year | 1.02 | | 1.68 |
| 1 year | 0.81 | | 4.11 |
| 3 years | 0.81 | | 4.11 |
| 5 years | 0.81 | | 5.28 |
| 10 years | 0.81 | | 5.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Khaled Kamel
CEO | Chief Executive Officer | - | - |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ahmed El-Nayeb
CHM | Chairman | - | 2001-12-31 |
Tamir Saeed
BRD | Director/Board Member | - | 2020-12-31 |
Norbert Lurz
BRD | Director/Board Member | - | 2020-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.50% | +8.00% | -39.19% | -51.09% | 15M | |
| +0.85% | -0.80% | +52.79% | +161.33% | 1,051B | |
| +1.23% | -1.53% | +54.58% | +59.08% | 609B | |
| +0.04% | +2.58% | +34.47% | +86.33% | 450B | |
| +0.78% | -0.71% | +29.28% | +24.10% | 330B | |
| +1.41% | +0.58% | +35.44% | +40.67% | 284B | |
| -0.27% | -1.87% | +22.34% | +22.51% | 263B | |
| -1.76% | +2.37% | -20.43% | -38.00% | 223B | |
| -1.42% | +0.80% | +24.27% | +57.50% | 198B | |
| -1.48% | +3.43% | +24.08% | +71.67% | 167B | |
| Average | +0.09% | +0.48% | +21.76% | +43.41% | 357.51B | |
| Weighted average by Cap. | +0.37% | +0.02% | +37.51% | +79.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.19B 23.3M 20.58M 18.83M 17.5M 32.66M 2.24B 33.44M 227M 89.18M 1.11B 87.5M 85.58M 3.79B | 1.55B 30.39M 26.84M 24.56M 22.82M 42.6M 2.93B 43.61M 296M 116M 1.45B 114M 112M 4.94B |
| Net income | 206M 4.03M 3.56M 3.26M 3.03M 5.65M 388M 5.79M 39.28M 15.44M 192M 15.15M 14.81M 656M | 283M 5.54M 4.89M 4.48M 4.16M 7.77M 533M 7.95M 53.96M 21.21M 264M 20.81M 20.35M 901M |
| Net Debt | -79.7M -1.56M -1.38M -1.26M -1.17M -2.19M -150M -2.24M -15.2M -5.97M -74.33M -5.86M -5.73M -254M | -110M -2.15M -1.9M -1.74M -1.62M -3.02M -207M -3.09M -20.97M -8.24M -103M -8.09M -7.91M -350M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-19 | EGP 1.350 | +1.50% | 52,080,619 |
| 26-07-16 | EGP 1.330 | -2.21% | 33,974,723 |
| 26-07-15 | EGP 1.360 | 0.00% | 99,891,776 |
| 26-07-14 | EGP 1.360 | +0.74% | 123,335,655 |
| 26-07-13 | EGP 1.350 | +1.50% | 136,430,983 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.350EGP
Average target price
1.570EGP
Spread / Average Target
+16.30%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MCRO Stock
Select your edition
All financial news and data tailored to specific country editions
